The treatment of dermatophytosis: Safety considerations

J Am Acad Dermatol 2000;43:S113-9.

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 43; no. 5; pp. S113 - S119
Main Author Smith, Edgar B.
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.11.2000
Subjects
Administration, Oral
Administration, Topical
Antifungal Agents - administration & dosage
Antifungal Agents - adverse effects
Antifungal Agents - therapeutic use
Dermatomycoses - drug therapy
Fluconazole - administration & dosage
Fluconazole - adverse effects
Fluconazole - therapeutic use
Humans
Itraconazole - administration & dosage
Itraconazole - adverse effects
Itraconazole - therapeutic use
Ketoconazole - administration & dosage
Ketoconazole - adverse effects
Ketoconazole - therapeutic use
Naphthalenes - administration & dosage
Naphthalenes - adverse effects
Naphthalenes - therapeutic use
Terbinafine
Online AccessGet full text

Cover

More Information
Summary:J Am Acad Dermatol 2000;43:S113-9.
ISSN:0190-9622
1097-6787
DOI:10.1067/mjd.2000.110379